Phase I/II trial of radiation with chemotherapy 'boost' for advanced squamous cell carcinomas of the head and neck: Toxicities and responses

Journal of Clinical Oncology

Volumn 17, Issue 8, 1999, Pages 2390-2395

  Garden, Adam S ^a   Glisson, Bonnie S ^a   Kian Ang, K ^a   Morrison, William H ^a   Lippman, Scott M ^a   Byers, Robert M ^a   Geara, Fady ^a   Clayman, Gary L ^a   Shin, Dong M ^a   Callender, David L ^a   Khuri, Fadlo R ^a   Goepfert, Helmuth ^a   Hong, Waun K ^a   Peters, Lester J ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION INJURY; SEPSIS; SKIN NECROSIS; SQUAMOUS CELL CARCINOMA;

EID: 0032784696     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.8.2390     Document Type: Article

References (38)

1. Ries L, Miller B, Hankey B, et al (eds): SEER Cancer Statistical Review 1973-1991: Section XII. Washington D.C., U.S. Department of Health and Human Services, Public Health Services, NIH Publication No. 94-2789, 1994, pp 216-228
2. Vokes EE, Weichselbaum RR, Lippman SM, et al: Head and neck cancer. N Engl J Med 328:184-194, 1993
3. Peters LJ, Goepfert H, Ang KK, et al: Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial. Int J Radiat Oncol Biol Phys 26:3-12, 1993
4. Vandenbrouck C, Eschwege F, De La Rouchefordiere A, et al: Squamous cell carcinoma of the pyriform sinus: Retrospective study of 351 cases treated at Institut Gustave-Roussy. Head Neck Surg 10:4-13, 1987
5. Tupchong L, Scott CB, Blitzer PH, et al: Randomized study of preoperative versus postoperative radiation therapy in advanced head and neck carcinoma: Long-term follow-up of RTOG study 73-03. Int J Radiat Oncol Biol Phys 20:21-28, 1991
6. Laramore G, Scott C, Al-Sarraf M, et al: Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report on intergroup study 0034. Int J Radiat Oncol Biol Phys 23:705-713, 1992
7. Ang KK, Peters LJ, Weber RS, et al: Concomitant radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 19:1339-1345, 1990
8. Horiot JC, Le Fur R, N'Guyen T, et al: Hyperfractionation versus conventional fractionation in oropharngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 25:231-241, 1992
9. Parsons JT, Mendenhall WM, Stringer SP, et al: Twice-a-day radiotherapy for squamous cell carcinoma of the head and neck: The University of Florida experience. Head Neck 15:87-96, 1993
10. Fu KK, Clery M, Ang KK, et al: Randomized phase I/II trial of two variants of accelerated fractionated radiotherapy regimens for advanced head and neck cancer: Results of RTOG 88-09. Int J Radiat Oncol Biol Phys 32:589-597, 1995
11. Wang C, Efird J, Nakfoor B, et al: Local control of T3 carcinomas after accelerated fractionation: A look at the "gap." Int J Radiat Oncol Biol Phys 35:439-441, 1996
12. Stuschke M, Thames HD: Hyperfractionated radiotherapy of human tumors: Overview of the randomized clinical trials. Int J Radiat Oncol Biol Phys 37:259-267, 1997
13. Wang C, Nakfoor B, Spiro I, et al: Role of accelerated fractionated irradiation for supraglottic carcinoma: Assessment of results. Cancer J Sci Am 3:88-91, 1997
14. Fu KK, Pajak TF, Marcial VA, et al: Late effects of hyperfractionated radiotherapy for advanced head and neck cancer: Long-term follow-up results of RTOG 83-13. Int J Radiat Oncol Biol Phys 32:577-588, 1995
15. Van den Bogaert W, van der Schueren E, Horiot JC, et al: The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: Long-term results and side effects. Radiother Oncol 35:91-99, 1995
16. Dische S, Saunders M, Barrett A, et al: A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 44:123-136, 1997
17. Horiot JC, Bontemps P, van den Bogaert W, et al: Accelerated fractionation (AF) compared to conventional fractionation (CF) improves locoregional control in the radiotherapy of advanced head and neck cancers: Results of the EORTC 22851 randomized trial. Radiother Oncol 44:111-121, 1997
18. Mak AC, Morrison WH, Garden AS, et al: Base-of-tongue carcinoma: Treatment results using concomitant boost radiotherapy. Int J Radiat Oncol Biol Phys 33:289-296, 1995
19. Gwozdz JT, Morrison WH, Garden AS, et al: Concomitant boost radiotherapy for squamous carcinoma of the tonsillar fossa. Int J Radiat Oncol Biol Phys 39:125-135, 1997
20. Withers H, Taylor J, Maciejewski B: The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol 27:131-146, 1988
21. The Department of Veterans Affairs Laryngeal Cancer Study Group: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324:1685-1690, 1992
22. Lefebvre J, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial. J Natl Cancer Inst 88:890-899, 1996
23. Byfield JE, Sharp TR, Frankel SS, et al: Phase I and II trial of five-day infused 5-fluorouracil and radiation in advanced cancer of the head and neck. J Clin Oncol 2:406-413, 1984
24. Marcial VA, Pajak TF, Mohiuddin M, et al: Concommitant cisplatin chemotherapy and radiotherapy in advanced mucosal squamous cell carcinoma of the head and neck. Cancer 66:1861-1868, 1990
25. Adelstein DJ, Saxton JP, Lavertu P, et al: A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: Preliminary results. Head Neck 19:567-575, 1997
26. Haffty BG, Son YH, Papac R, et al: Chemotherapy as an adjunct to radiation therapy in the treatment of squamous cell carcinoma of the head and neck: Results of the Yale Mitomycin Randomized Trials. J Clin Oncol 15:268-276, 1997
27. Brockstein B, Haraf DJ, Stenson K, et al: Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, and hydroxyurea with granulocyte colony-stimulating factor supprt for patients with poor-prognosis cancer of the head and neck. J Clin Oncol 16:735-744, 1998
28. Lo TC, Wiley ALJ, Ansfield F, et al: Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: A randomized study. Am J Roentgenol 126:229-235, 1976
29. Fu KK, Phillips TL, Silverberg IJ: Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: Update of a Northern California Oncology Group randomized trial. J Clin Oncol 5:1410-1418, 1987
30. Brizel DM, Leopold KA, Fisher SR, et al: A phase I/II trial of twice daily irradiation and concurrent chemotherapy for locally advanced squamous cell carcinoma of the head and neck. Int J Radiat Oncol Biol Phys 28:213-220, 1994
31. Taylor SG, Murthy AK, Vannetzel JM, et al: Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatmetn in advanced head and neck cancer. J Clin Oncol 12:385-395, 1994
32. Wong WW, Mick R, Haraf DJ, et al: Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer. Int J Radiat Oncol Biol Phys 29:153-162, 1994
33. Forastiere AA, Metch B, Schuller DE, et al: Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: A Southwest Oncology Group study. J Clin Oncol 10:1245-1251, 1992
34. Jacobs C, Lyman G, Velez-Garcia E, et al: A phase III randomized study comparing cisplatin and fluorouracil as single agents and in combination for advanced squamous cell carcimona of the head and neck. J Clin Oncol 10:257-263, 1992
35. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
36. Vokes EE, Kies M, Haraf DJ, et al: Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: Impact on the natural history of the disease. J Clin Oncol 13:876-883, 1995
37. Shin DM, Glisson BS, Khuri FR, et al: Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma. J Clin Oncol 16:1325-1330, 1998
38. Brizel D, Albers M, Fisher S, et al: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 338:1798-1804, 1998